Role
The group leads national initiatives to improve the medical research ecosystem. Its key priorities include:
- establishing a National One Stop Shop (NOSS) to streamline clinical trials through a consistent, national system and set of regulations
- developing quality standards and an accreditation scheme for Human Research Ethics Committees (HRECs) and their host institutions
- supporting health services in fully implementing the National Clinical Trials Governance Framework
- continuously maintaining the National Standard Operating Procedures for Clinical Trials in Australia
- developing and implementing future reform initiatives to improve the health and medical research ecosystem and to improve health outcomes for all Australians.
A key objective of the IGPRG is to make Australia a preferred destination for medical research including clinical trials.
Members
The government appointed Emeritus Professor Ian Chubb AC FAA FTSE as Chair of the IGPRG.
Senior officials from state and territory governments are members of the IGPRG along with other key stakeholders.
Meetings
The IGPRG meets bi-monthly or more frequently if required.
Newsletters
See previous IGPRG newsletters.
Related committees or groups
- Industry Advisory Group (IAG)
- Stakeholder Advisory Group (SAG)
- Research Operations and Technical Working Group (ROTWG)
- Change Management, Rollout and Implementation Working Group (CMRIWG)
- Ethics Committee Advisory Group (ECAG)
Learn more
COVID-19: Guidance on clinical trials for institutions, HRECs, researchers and sponsors
Collaborative research agreement template – for projects not involving clinical trials
Contact
Please contact us for more information about the IGPRG.